HCF LOGO
Meeting category
Date(s)
14 Jun 2022 - 15 Jun 2022
Program Language
English
Meeting type
Virtual Meeting
CME Credits
4
Organizer

Asia-Pacific HIV Clinical Forum 2022

Related Enduring Materials

Enduring Materials
Final Program

All times indicated in the program are in Indochina Time (ICT). Click here to convert the time into your time zone: www.worldtimebuddy.com

DAY 1 | Tuesday, 14 June 2022
Session 1: Antiretroviral Therapy 2022 - State of ART Plenary Lectures -
Session Chair:
Sivaporn Gatechompol, MD
Thai Red Cross AIDS Research Centre, Thailand
14:00 ICT
Welcome, Introductions, and Goals - Day 1
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
14:05 ICT
International and Asian Country Guidelines - Similarities and Differences
Sivaporn Gatechompol, MD
Thai Red Cross AIDS Research Centre, Thailand
14:25 ICT
Resistance Considerations in Choice of Regimen
14:45 ICT
Pharmacological Considerations in Choice of Regimen
Tim Cressey, MSc, PhD
Chiang Mai University, Thailand
Session 2: HIV Prevention in 2022 -
Session Chair:
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
15:45 ICT
Update on Pharmacologic Options for HIV Prevention
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
16:05 ICT
Suitability of Oral versus Intra-Muscular PrEP in Asian Countries
Stephane Wen-Wei Ku, MD
Taipei City Hospital Renai, Taiwan
16:25 ICT
Clinical Case (Focused on Prevention)
Jakkrapatara Boonruang, MD
Institute of HIV and Research Innovation, Thailand
17:05 ICT
Closure of Program - Day 1
DAY 2 | Wednesday, 15 June 2022
Session 3: Starting Antiretroviral Therapy in 2022 -
Session Chair:
Kiat Ruxrungtham, MD
Chulalongkorn University, Thailand
14:00 ICT
Welcome, Introductions, and Goals - Day 2
Kiat Ruxrungtham, MD
Chulalongkorn University, Thailand
14:05 ICT
Therapeutic Options for Starting Antiretroviral Therapy
Nagalingeswaran Kumarasamy, MD, FRCP, PhD
Voluntary Health Services, Infectious Diseases Medical Centre, India
14:25 ICT
Early Diagnosis and Same-Day ART
Praphan Phanuphak, MD, PhD
Chulalongkorn University, Thailand
14:45 ICT
Oral Dual Antiretroviral Therapy, Dual ART: Implementing Consideration
Kiat Ruxrungtham, MD
Chulalongkorn University, Thailand
Session 4: Switching Antiretroviral Therapy in 2022 -
Session Chair:
Nagalingeswaran Kumarasamy, MD, FRCP, PhD
Voluntary Health Services, Infectious Diseases Medical Centre, India
15:45 ICT
Management of Major Comorbidity in the Region
Linghua Li, MD, PhD
Guangzhou Eighth People’s Hospital, China
16:05 ICT
Constructing an Effective Treatment Regimen after ART Failure
Nicholas Paton, MD, FRCP
National University of Singapore, Singapore
16:25 ICT
Clinical Case (Focused on Treatment Switching)
Sazali Basri, MBBS, MMed
University of Malaya, Malaysia
Overview
Image
HCF Asia Pacific
Why Should You Join

The Asia-Pacific HIV Clinical Forum is the pre-conference to the Asia-Pacific AIDS and Co-Infections Conference (APACC), the leading HIV Conference in the region.

Get the latest updates on antiretroviral therapy and other pharmacological options.
Discover the ins and outs of creating an effective regimen after a ART failure.
Network and ask your questions to leading experts in the roundtable discussions.

What's New
  • Registration is now open to view on demand for the Asia-Pacific HIV Clinical Forum.
  • To stay updated on the latest developments, make sure you are signed up for our newsletter.
Welcome

The Asia-Pacific HIV Clinical Forum 2022 provided an independent scientific program involving the world’s leading experts and was specifically designed for HIV healthcare professionals in the Asia-Pacific region and focused on optimizing treatment for their patients. 

This program featured challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and the sharing of knowledge within the HIV-treating community. The program included virtual networking opportunities for community building providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV, involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience and present results from their ongoing and completed cohorts/research programs.

Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.

Program Chairs
Jonathan Schapiro
Jonathan Schapiro
MD
General Information 
COVID-19 Update
The Asia Pacific HIV Clinical Forum 2022 is scheduled to take place as a virtual forum from 14-15 June 2022. To keep the meeting accessible to all our participants, virtual participants can attend plenary sessions and roundtable discussions during the day of the meeting.

We are available to answer any questions you may have about your participation at the Asia Pacific HIV Clinical Forum 2022. For more information, please contact Ms. Olivia Zhang at olivia.zhang@amededu.com.

To stay updated on developments in relation to this forum meeting, make sure you are signed up for our newsletter.
Who Should Attend?
Primary: Medical doctors involved in the management and treatment of people living with HIV in the region

Secondary: Researchers

Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV.
Meeting Objectives
With the HIV Clinical Forum program, we aim to:

• Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
• Create a platform for interactive information exchange on novel treatment strategies and options
• Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:

• Describe the similarities and differences between the different international/ regional treatment guidelines.
• Select an optimal treatment strategies for their patients understanding the various clinical parameters affecting the choice of regimens.
• Recall to latest developments for HIV preventions.
• Discuss the suitability of oral versus intramuscular injections for pre-exposure prophylaxis.
• Summarize and compare the options for starting antiretroviral treatment.
• Describe the concept of early diagnosis and rapid start.
• Review the treatment options for patients failing on their current regimen.
Practical Information 

We trust that the following information (in alphabetical order) will assist you in organizing your participation in the Asia-Pacific HIV Clinical Forum 2022.

Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Language
The official language of the forum is English. Simultaneous translation into Chinese will be provided.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Accreditation

Asia-Pacific HIV Clinical Forum 2022 is accredited by the following societies. To claim the CME points, members of the societies must log on to the virtual congress portal and attend the full sessions. Additional information such as membership number or license number might be required after the event.

Hong Kong Academy of Medicine (HKAM)
HKAM

Asia-Pacific HIV Clinical Forum 2022 is accredited by the Hong Kong Academy of Medicine (HKAM) up to 5 credits. To claim the CME points, members of the HKAM must log on to the virtual congress portal and attend the full sessions. 

 College 

   14 June 

   15 June 

Physicians 

      2.5

 CME Points

      2.5 

 CME Points

Taiwan AIDS society
Taiwan AIDS Society

Asia-Pacific HIV Clinical Forum 2022 is accredited by the Taiwan AIDS Society with 4 credits. To claim the CME points, members of the Taiwan AIDS Society must log on to the virtual congress portal and attend the full sessions. 

European Accreditation Council for Continuing Medical Education (EACCME®)
European Accreditation Council for Continuing Medical Education (EACCME®)
Asia-Pacific HIV Clinical Forum 2022, Online, Netherlands, 14/06/2022 - 15/06/2022

has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®)

for a maximum of 4 European CME credits (ECMEC®s).

Through an agreement between the Union Européenne des Médecins Spécialistes  and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities. 

Committees
Program Director
Jonathan Schapiro
Jonathan Schapiro
MD
Local Chair 2022
Ruxrungtham, Kiat
Kiat Ruxrungtham
MD
Support
ViiV Healthcare

The Online Asia-Pacific HIV Clinical Forum 2022 is supported by an independent educational grant from ViiV Healthcare.

​​ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Endorsers
Previous Editions
Top-Rated Materials from Previous Editions

ARV Considerations for Transgender People Living with HIV - Madeline Deutsch, MD, MPH

Asia-Pacific HIV Clinical Forum 2021

Ratings previous edition
Content is relevant to my practice
4.7
(134)
Content was free from commercial bias
4.4
Overall event experience
4.9
Sorry… This form is closed to new submissions.